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Abstract 
The COVID-19 pandemic swept across the world rapidly infecting millions of people. An efficient 
tool that can accurately recognize important clinical concepts of COVID-19 from free text in 
electronic health records (EHRs) will be significantly valuable to accelerate various applications 
of COVID-19 research. To this end, the existing clinical NLP tool CLAMP is quickly adapted to 
COVID-19 information. An automated tool called COVID-19 SignSym is built, which can extract 
signs/symptoms and their eight attributes (body location, severity, temporal expression, subject, 
condition, uncertainty, negation, and course) from clinical text. The extracted information is also 
mapped to standard clinical concepts in the common data model of OHDSI OMOP. Evaluations 
on clinical notes and medical dialogues demonstrate promising results. This tool is freely 
accessible to the community as a downloadable package of APIs 
(https://clamp.uth.edu/covid/nlp.php). We believe COVID-19 SignSym will provide fundamental 
supports to the secondary use of EHRs, thus accelerating the global research of COVID-19.  
Introduction  
The COVID-19 pandemic1 swept across the world rapidly infecting more than two million people 
in the US and resulting in the death of almost 120,000 at a mortality rate of about 6%.2  Scientists 
and researchers from multiple organizations world widely have been working collaboratively 
targeting effective prevention and treatment strategies.3 Research findings, data resources, 
informatics tools and technologies are being openly shared, aiming to speed up the fight against 
such emerging pandemic. 45 
Facilitated by PubMed, large datasets of literature articles relevant to COVID-19 are being 
accumulated and shared at a rapid pace in the medical community.6 For example, the COVID-19 
Open Research Dataset (CORD-19) has already accumulated more than 75, 000 full text articles.6 
Based on such resources, many tools have been developed using natural language processing 
(NLP) techniques to unlock COVID-19 information from literature, including tools of search 
engines, information extraction and knowledge graph building.78 As another important data source 
for COVID-19 research, Electronic Health Records (EHRs) store the clinical data of COVID-19 
patients, which are critical for various applications, such as clinical decision support, predictive 
modeling and phenotyping-based cohort stratification.910 An efficient tool that can accurately 
recognize important clinical concepts of COVID-19 from clinical notes will be significantly 
valuable to save time and accelerate the chart-review workflow.  
Despite that several large consortia have been formed to construct large clinical data networks for 
COVID-19 research, such as The National COVID Cohort Collaborative (N3C)11 and the 
international EHR-derived COVID-19 Clinical Course Profiles (4CE)12, very few informatics 
tools have been developed for clinical notes of COVID-19. As far as the authors know, the only 
tool available in public is MedTagger.13 Based on a pre-collected list of symptoms and synonyms, 
MedTagger recently provides a rule-based tool, which mainly extracts COVID-19 sign/symptoms 
and their three attributes of certainty, status (i.e., HistoryOf or Present) and experiencer (i.e., 
Patient or others).14 However, limited sign/symptom lists may not be sufficient to recognize or 
normalize the varying expressions in clinical text; other important attributes critical to unfold the 
clinical course and prognosis of patients are also not recognized in this tool, including the onset 
time, severity, course and body location. On the other hand, some existing clinical NLP tools can 
already recognize signs/symptoms and a more comprehensive set of attributes with good 
performances. Given that COVID-19 signs/symptoms are a subset of a more general scope of 
clinical problems, existing tools can be leveraged and quickly adapted for COVID-19 information 
extraction. 
Therefore, in this study, we built an automatic NLP tool, named as COVID-19 SignSym, to extract 
COVID-19 signs/symptoms and their eight attributes (body location, severity, temporal 
expression, subject, condition, uncertainty, negation, and course), by adapting existing pipelines 
in the CLAMP software (Clinical Language Annotation, Modeling, and Processing Toolkit).1516 
The extracted entities will also be normalized to standard terms in OHDSI OMOP CDM 
(Observational Medical Outcomes Partnership, Common Data model)17 automatically. The set of 
signs and symptoms of COVID-19 is collected from four resources, including the case record form 
of WHO (World Health Organization), National COVID Cohort Collaborative, dictionaries in 
MedTagger and in-house dictionaries from John Hopkins. In total, 55 signs and symptoms are 
collected from these sources. UMLS CUIs of these signs and symptoms are assigned manually, 
their synonyms in UMLS are also extracted to extend the dictionary. A hybrid method combining 
deep learning models, lexicons and pattern-based rules is used to build COVID-19 SignSym. We 
believe this tool will provide fundamental supports to the secondary use of EHRs, thus accelerating 
the global research of COVID-19.  
Methods 
Figure 1 illustrates an overview of the workflow for building COVID-19 SignSym. This workflow 
mainly consists of five steps: (1) Information model design to define the information scope of 
COVID-19, i.e. semantic types of clinical concepts and relations, to be extracted; (2) 
Sign/symptom collection to gather COVID-19 signs/symptoms from multiple sources; (3) 
Information extraction and normalization to extract and normalize COVID-19 signs/symptoms and 
eight types of attributes, including body location, severity, temporal expression, subject, condition, 
uncertainty, negation, and course. Hybrid approaches are used to adapt existing NLP pipelines in 
CLAMP for COVID-19 information extraction. Lexicons of COVID-19 signs/symptoms and 
pattern-based rules are integrated with CLAMP to optimize the performance. All signs/symptoms 
in free text are extracted first, which are filtered by lexicons and UMLS CUIs to maintain COVID-
19 signs/symptoms.  (4) OMOP Mapping to convert the output information into the format of 
OMOP CMD.   
 
 
Figure 1. An overview of the NLP pipeline for COVID-19 sign/symptom extraction and normalization 
Dataset 
Four clinical datasets were used for building and evaluating the pipeline:  
(1) MIMICIII: this data set contains clinical notes from intensive patient care. 200 discharge 
summaries are randomly selected, with 50% for model tuning and 50% for open test. In total, the 
selected dataset contains 17, 208 sentences and 329, 044 tokens.  
(2) Medical dialogues: this data set contains medical dialogues related to COVID-19 collected 
from an online website between patients and doctors.18 Fifty dialogues were randomly selected for 
external evaluation of COVID-19 SignSym. In total, the selected dataset contains 1,162 sentences 
and 22,324 tokens.  
(3) Clinical notes from Johns Hopkins: This dataset contains 334 clinical notes of 40 patients and 
includes relevant note types such as H&P, Critical Care Notes, Progress Notes, and ED Notes, 
focusing specifically on the notes created within 48 hours before and after hospital admission. 
Notes are pre-processed by Hopkins in-house section identification tools, and only the relevant 
narrative parts, particularly the chief complaint and history of the present illness sections are 
extracted. For each of the 40 patients, each symptom was labeled as present or not-present, 
resulting in over 467 manually annotated symptoms. These gold standard labels are then used to 
validate COVID-19 SignSym. In total, the clinical notes in this dataset contain 13,397 sentences 
and 121,802 tokens.  
Information model 
The information model followed by the COVID-19 SignSym is illustrated in Figure 2. In addition 
to mentions of signs and symptoms, eight important attributes and their relations are also 
recognized: (1) Severity: indicates the severity degree of a sign/symptom; (2) Negation: indicates 
a sign/symptom was negated; (3) Temporal information: indicates the time period or specific time 
the sign/symptom started; (4) Subject: indicates who experienced the sign/symptom; (5) 
Uncertainty: indicates a measure of doubt into a statement about a sign/symptom; (6) Condition: 
indicates conditional existence of sign/symptoms under certain circumstances; (7) Body location: 
represent an anatomical location of the sign/symptom; (8) Course: indicates progress or decline of 
a sign/symptom. Examples of attribute values are illustrated in Figure 2. * indicates their default 
values. 
 
Figure 2. Information model of COVID-19 signs/symptoms and their attributes. 
 
Lexicon building for COVID-19 signs and symptoms 
Leveraging the community efforts, COVID-19 signs and symptoms are collected from five 
sources: (1) WHO case record form: 26 signs and symptoms were collected from the SIGNs AND 
SYMPTOMS ON ADMISSION section of the case record form provided by WHO.19 (2) National 
COVID Cohort Collaborative: 15 signs and symptoms were collected from the diagnosis table 
shared by the national COVID cohort collaborative as phenotyping information.11 (3) MedTagger 
Lexicon: 17 signs and symptoms together with their 136 synonyms were collected from the lexicon 
in MedTagger.14 (4) Lexicon from Johns Hopkins: 14 signs and symptoms, and 337 synonyms 
were collected from an in-house lexicon of Johns Hopkins. UMLS CUIs of these signs and 
symptoms (in total 124) were also assigned manually, with their UMLS synonyms collected. After 
removing redundancy,  55 signs and symptoms and 2, 022 synonyms were collected from these 
four sources. Table 1 illustrates ten signs/symptoms of COVID-19, together with their CUIs and 
example synonyms. A comprehensive list is included in Supplementary Table 1. 
 
Table 1 Ten Examples of COVID-19 Signs and Symptoms, their synonyms and UMLS CUIs 
Sign and Symptom Example Synonym UMLS CUI  
Sore throat throat pain, throat soreness C0242429  
Headache head pain, cephalalgia C0018681  
Fever Hyperthermia, febrile C0015967  
Fatigue Tired, energy loss C0015672  
Abdominal pain stomach pain, gut pain C0000737  
Altered consciousness Consciousness Disturbances, Impaired 
consciousness 
C0234428  
Short of breath Sob, gasp, Dyspnea C0013404  
Dry cough cough unproductive, nonproductive cough C0850149  
Vomiting throw up, puke C0042963 
Diarrhea loose stool, watery stool C0011991 
Text processing  
Disease-attributes pipeline in CLAMP: The disease-attribute pipeline in CLAMP was adapted 
for COVID-19 information extraction in this study. This pipeline is built to automatically extract 
mentions of problems and their eight attributes from clinical text. The definition of problems 
follows that used in the i2b2 2010 shared task, which consists of eleven semantic types in UMLS 
(e.g., sign or symptom, pathologic functions, disease or syndrome, etc.).20 Besides, the definitions 
of attributes follows that used in the SemEval 2015 Shared Task 14.21 
 
Adapting CLAMP for COVID-19 Sign/Sym: Besides, the lexicons collected previously are also 
used in an additional step of dictionary-lookup, to improve the coverage of recognized COVID-19 
signs and symptoms.  Furthermore, regular expressions and rules are also applied in a 
postprocessing step to boost the performance of attribute recognition. 
 
Concept normalization Mentions of problems and attributes are normalized to standard concepts 
using the UMLS encoder module of CLAMP, which are also built on a hybrid method of semantic 
similarity based ranking and rules of concept-prevalence in UMLS.22 Both CUIs and preferred 
terms in UMLS will be output for each recognized entity. 
 
Filtering of COVID-19 Signs/Symptoms: Once medical problems are automatically recognized 
and normalized to UMLS CUIs, they will be filtered by the pre-collected lexicons and CUIs of 
COVID-19 signs and symptoms.  
 
OMOP Mapping The remaining signs/symptoms and their attributes will also be mapped to 
standard concepts in OMOP CDM. The OMOP encoder module of CLAMP is used for this 
purpose, which applies a similar approach as in the UMLS encoder module, with a different scope 
of standard concepts and identifiers. 
Evaluation 
Evaluation criteria: (1) The performances of NER and relation extraction are evaluated using 
precision, recall and F-measure (F1); (2) The performance of concept normalization is evaluated 
using accuracy; (3) The performance of patient-level COVID-10 diagnosis is evaluated using 
precision, recall and F-measure. 
 
Evaluation setup: (1) 200 discharge summaries are randomly selected from MIMICIII; 100 of 
them are used for error analysis and optimize the SignSym pipeline. After that, the information 
extraction performance of COVID-19 SignSym are evaluated on another 100 discharge summaries 
from MIMICIII as the open test. In addition, it is evaluated on fifty posts of COVID-19 related 
dialogues between patients and doctors online as an external test. (2) Besides, 1, 000 output CUIs 
are randomly selected from the 100 discharge summaries and manually reviewed to evaluate the 
performance of clinical concept normalization. (3) Moreover, a use case of identifying patients 
symptoms at presentation from notes generated within 48 hours before and after hospital admission 
is used to validate the effectiveness of COVID-19 SignSym. Specifically, positive and negative 
signs and symptoms in 334 clinical notes of 40 patients from Johns Hopkins Hospitals are 
extracted, and then aggregated into patient-level scores to determine all presenting symptoms for 
each patient. In total, 467 unique signs and symptoms are manually annotated and normalized for 
the 40 patients.   
 
Results 
Information extraction: Performances of COVID-19 SignSym for information extraction are 
illustrated in Table 2; both performances on clinical text and medical dialogues are reported. The 
95% confidence intervals (CIs) are also reported in Table 2, by considering each clinical note or 
each post of medical dialogues as a sample. Promising results were achieved on sign/symptom 
extraction, with a F-measure of 0.992 ± 0.008 on clinical text and 0.99 ± 0.01 on medical dialogue. 
As for recognizing attributes of signs/symptoms, the tool yielded better performances on clinical 
text than on medical dialogue (e.g., F-measure: Has_Body location 0.986 ± 0.014 vs. 0.964 ± 
0.036, Has_Temporal 0.984 ± 0.016 vs. 0.926 ± 0.074). Some semantic types have low frequencies 
in the test datasets, thus have large CIs. For example, there are only six instances of Subject (F-
measure: 0.771 ± 0.229) in clinical notes and 3 instances of Course in the medical dialogues (F-
measure: 0.579 ± 0.421), leading to large CIs. 
 
Table 2. Information extraction performances of COVID-19 SignSym on clinical text and medical 
dialogues. 95% confidence interval is reported for each result. 
 Clinical text Medical dialogue 
 Precision Recall F1 Precision Recall F1 
Sign/Symptom 0.98 ± 
0.01 
0.985 ± 
0.009 
0.992 ± 
0.008 
0.967 ± 
0.015 
0.988 ± 
0.009 
0.99 ± 
0.01 
Attribute extraction 
Has_Body location 0.982 ± 
0.017 
0.95 ± 
0.03 
0.986 ± 
0.014 
0.933 ± 
0.058 
0.883 ± 
0.076 
0.964 ± 
0.036 
Has_Temporal  0.916 ± 
0.067 
0.97 ± 
0.03 
0.984 ± 
0.016 
0.83 ± 
0.081 
0.849 ± 
0.078 
0.926 ± 
0.074 
Has_Negation 0.976 ± 
0.024 
0.961 ± 
0.034 
0.991 ± 
0.009 
0.923 ± 
0.077 
0.831 ± 
0.144 
0.968 ± 
0.032 
Has_Condition 0.949 ± 
0.051 
0.949 ± 
0.051 
0.99 ± 
0.01 
0.874 ± 
0.117 
0.799 ± 
0.145 
0.939 ± 
0.061 
Has_Course 0.926 ± 
0.074 
0.894 ± 
0.105 
0.989 ± 
0.011 
0.646 ± 
0.354 
0.646 ± 
0.354 
0.579 ± 
0.421 
Has_Uncertainty 0.941 ± 
0.059 
0.889 ± 
0.103 
0.983 ± 
0.017 
0.82 ± 
0.166 
0.785 ± 
0.181 
0.932 ± 
0.068 
Has_Severity 0.926 ± 
0.074 
0.926 ± 
0.074 
0.926 ± 
0.074 
0.84 ± 
0.158 
0.801 ± 
0.183 
0.952 ± 
0.048 
Has_Subject 0.771 ± 
0.229 
0.771 ± 
0.229 
0.771 ± 
0.229 
0.860 ± 
0.13 
0.753 ± 
0.164 
0.923 ± 
0.077 
 
Concept Normalization: Based on manual check of 1, 000 gold standard entities and their 
automatically assigned CUIs, COVID SignSym obtained an accuracy of 95% for concept 
normalization. 
COVID-19 sign/symptom presentation of patients:  In comparison with manually assigned 
signs/symptoms of each patients, the tool yielded a precision of 0.928, a recall of 0.957, and a F-
measure of 0.942. 
Tool Availability  
It is freely accessible to the community via a downloadable package of APIs 19 . A visualization 
of the output format is illustrated in Figure 3. 
 
Figure 3. An output illustration of the COVID-19 sign/symptom extraction tool 
Discussion 
There is an urgent demand of automatic tools that can extract COVID-19 information from clinical 
text. This paper presents our preliminary work to quickly adapt an existing high-performance 
clinical NLP tool for COVID-19 sign/symptom extraction and normalization, leveraging COVID-
19 lexicons provided from multiple resources. The tool of COVID-19 SignSym is evaluated on 
clinical notes and medical dialogues. Experimental results demonstrate that it achieves promising 
results in practical settings. The workflow of this study can be generalized to other use cases, where 
existing clinical NLP tools need to be customized for specific information needs within a short 
time.  
Errors present in the outputs of COVID-19 SignSym are analyzed carefully for further 
improvement. One type of common errors is partial recognition of named entities.  For example, 
“cough” is recognized, instead of “cough productive of yellow sputum”. More patterns of signs 
and symptoms are needed to improve the coverage. Another type of common errors is related to 
cross sentence relations. For example, many temporal expressions are not in the same sentence 
with the relevant signs/symptoms. Besides, some attributes such as conditions are modifying 
signs/symptoms in a list of multiple items. Document structure and intra sentence relations need 
to be handled in the next step.  
Limitations and future work: this work has several limitations and future works are needed. (1) 
First, performances on two COVID-19 datasets are evaluated and reported, additional evaluations 
are needed to further refine the tool and increase its generalizability; (2) Currently, only 
sign/symptoms and their attributes are extracted, additional works will be conducted for more 
related information such as comorbidities and medications; (3) The output information will also 
be mapped to other clinical data standards such as FHIR in the near future, to facilitate clinical 
operations and other applications. 
Conclusion 
This paper presents an automatic tool, named as COVID-19 SignSym, to extract and normalize 
signs/symptoms and their eight attributes from clinical text using NLP techniques. COVID-19 
SignSym achieved promising results on clinical notes and medical dialogues. It is freely accessible 
to the community via a downloadable package of APIs. So far, COVID-19 SignSym has been 
applied by eight different institutions in academia and industry, which we believe will provide 
fundamental supports to the secondary use of EHRs for COVID-19 research upon a wide 
dissemination.  
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